CLINICAL TRIALS PROFILE FOR ERTACZO

All Clinical Trials for ERTACZO

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00856596 ↗	Once a Day Topical Treatment for Athlete's Foot Fungus Inbetween the Toes in Males and Females	Unknown status	Johnson & Johnson	Phase 3	2009-03-01	The topical cream, Sertaconazole (Ertaczo), has been FDA approved for the treatment of athlete's foot using twice a day dosing for 4 weeks. This study wants to see if sertaconazole will work equally as well with once a day dosing for 4 weeks for athlete's foot.
NCT00856596 ↗	Once a Day Topical Treatment for Athlete's Foot Fungus Inbetween the Toes in Males and Females	Unknown status	Jamaica Hospital Medical Center	Phase 3	2009-03-01	The topical cream, Sertaconazole (Ertaczo), has been FDA approved for the treatment of athlete's foot using twice a day dosing for 4 weeks. This study wants to see if sertaconazole will work equally as well with once a day dosing for 4 weeks for athlete's foot.

Clinical Trial Conditions for ERTACZO

Condition Name

Condition Name for ERTACZO
Intervention	Trials
Athlete's Foot	1
Foot Fungus	1
Ringworm	1
Tinea Pedis	1

Condition MeSH

Condition MeSH for ERTACZO
Intervention	Trials
Tinea Pedis	1
Tinea	1

Clinical Trial Locations for ERTACZO

Trials by Country

Trials by Country for ERTACZO
Location	Trials
United States	1

Trials by US State

Trials by US State for ERTACZO
Location	Trials
New York	1

Clinical Trial Progress for ERTACZO

Clinical Trial Phase

Clinical Trial Phase for ERTACZO
Clinical Trial Phase	Trials
Phase 3	1

Clinical Trial Status

Clinical Trial Status for ERTACZO
Clinical Trial Phase	Trials
Unknown status	1

Clinical Trial Sponsors for ERTACZO

Sponsor Name

Sponsor Name for ERTACZO
Sponsor	Trials
Johnson & Johnson	1
Jamaica Hospital Medical Center	1

Sponsor Type

Sponsor Type for ERTACZO
Sponsor	Trials
Industry	1
Other	1